Revealing anti-PD-1 resistance mechanisms in HCC: A path towards novel combination immunotherapies

被引：5
|
作者：
Barcena-Varela, Marina [1 ,2 ,3 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Oncol Sci, Hess CSM Bldg Floor 6 Room 201 1470 Madison Ave, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Med, Liver Canc Program,Div Liver Dis, New York, NY 10029 USA
[3] Icahn Sch Med Mt Sinai, Precis Immunol Inst Dept, New York, NY 10029 USA
来源：
JOURNAL OF HEPATOLOGY | 2022年 / 77卷 / 01期
关键词：
HEPATOCELLULAR-CARCINOMA;
D O I：
10.1016/j.jhep.2022.04.020
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：9 / 11
页数：3
相关论文
共 50 条
  • [1] Transcriptional Mechanisms of Resistance to Anti-PD-1 Therapy
    Ascierto, Maria L.
    Makohon-Moore, Alvin
    Lipson, Evan J.
    Taube, Janis M.
    McMiller, Tracee L.
    Berger, Alan E.
    Fan, Jinshui
    Kaunitz, Genevieve J.
    Cottrell, Tricia R.
    Kohutek, Zachary A.
    Favorov, Alexander
    Makarov, Vladimir
    Riaz, Nadeem
    Chan, Timothy A.
    Cope, Leslie
    Hruban, Ralph H.
    Pardoll, Drew M.
    Taylor, Barry S.
    Solit, David B.
    Iacobuzio-Donahue, Christine A.
    Topalian, Suzanne L.
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (12) : 3168 - 3180
  • [2] The "Tricky Business" of Identifying Mechanisms of Resistance to Anti-PD-1
    Wilmott, James S.
    Rizos, Helen
    Scolyer, Richard A.
    Long, Georgina V.
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (12) : 2921 - 2923
  • [3] Tissue biomarkers of response to anti-PD-1 immunotherapies in melanoma
    Adam, Julien
    Tomasic, Gorana
    Robert, Caroline
    [J]. ANNALES DE PATHOLOGIE, 2017, 37 (01) : 55 - 60
  • [4] Development of novel combination cancer immunotherapy using anti-PD-1 and anti-PD-L1 antibody
    Hasegawa, Hirotaka
    Sugiyama, Daisuke
    Kanda, Mitsuro
    Hayashi, Masamichi
    Tanaka, Chie
    Yamada, Suguru
    Nakayama, Goro
    Koike, Masahiko
    Nomoto, Shuji
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    Nishikawa, Hiroyoshi
    [J]. CANCER SCIENCE, 2021, 112 : 741 - 741
  • [5] Mechanisms of resistance to anti-PD-1 immunotherapy through interferon pathway mutations
    Zaretsky, Jesse
    Garcia-Diaz, Angel
    Shin, Daniel S.
    Escuin-Ordinas, Helena
    Hugo, Willy
    Hu-Lieskovan, Siwen
    Eroglu, Zeynep
    Torrejon, Davis Y.
    Tumeh, Paul C.
    Lo, Roger S.
    Ribas, Antoni
    [J]. CANCER RESEARCH, 2017, 77
  • [6] Phase I Study of Androgen Deprivation Therapy in Combination with Anti-PD-1 in Melanoma Patients Pretreated with Anti-PD-1
    Robert, Caroline
    Lebbe, Celeste
    Lesimple, Thierry
    Lundstrom, Eija
    Nicolas, Valerie
    Gavillet, Bruno
    Crompton, Philippa
    Baroudjian, Barouyr
    Routier, Emilie
    Lejeune, Ferdy J.
    [J]. CLINICAL CANCER RESEARCH, 2023, 29 (05) : 858 - 865
  • [7] Proposing the best MET inhibitor to improve anti-PD-1 efficacy in HCC
    de Azevedo, Ricardo A.
    Turner, Broderick
    Jayaprakash, Priyamvada
    Bhanu, Krithikaa Rajkumar
    Srinivasamani, Anupallavi
    Morrow, Brittany
    Winkler, Michelle
    Hedge, Shweta Mahendra
    Liu, Arthur
    Slay, Ravaen
    Curran, Michael A.
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [8] Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study
    Manson, Guillaume
    Maria, Alexandre Thibault Jacques
    Poizeau, Florence
    Danlos, Francois-Xavier
    Kostine, Marie
    Brosseau, Solenn
    Aspeslagh, Sandrine
    Du Rusquec, Pauline
    Roger, Maxime
    Pallix-Guyot, Maud
    Ruivard, Marc
    Dousset, Lea
    Grignou, Laurianne
    Psimaras, Dimitri
    Pluvy, Johan
    Quere, Gilles
    Grados, Franck
    Duval, Fanny
    Bourdain, Frederic
    Maigne, Gwenola
    Perrin, Julie
    Godbert, Benoit
    Taifas, Beatris Irina
    Forestier, Alexandra
    Voisin, Anne-Laure
    Martin-Romano, Patricia
    Baldini, Capucine
    Marabelle, Aurelien
    Massard, Christophe
    Honnorat, Jerome
    Lambotte, Olivier
    Michot, Jean-Marie
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [9] Coronary Toxicities of Anti-PD-1 and Anti-PD-L1 Immunotherapies: a Case Report and Review of the Literature and International Registries
    Ferreira, Marion
    Pichon, Eric
    Carmier, Delphine
    Bouquet, Emilie
    Pageot, Cecile
    Bejan-Angoulvant, Theodora
    Campana, Marion
    Vermes, Emmanuelle
    Marchand-Adam, Sylvain
    [J]. TARGETED ONCOLOGY, 2018, 13 (04) : 509 - 515
  • [10] Combination of Fruquintinib and Anti-PD-1 for the Treatment of Colorectal Cancer
    Wang, Yuanyuan
    Wei, Bin
    Gao, Jianhua
    Cai, Xiaomin
    Xu, Lingyan
    Zhong, Haiqing
    Wang, Binglin
    Sun, Yang
    Guo, Wenjie
    Xu, Qiang
    Gu, Yanhong
    [J]. JOURNAL OF IMMUNOLOGY, 2020, 205 (10): : 2905 - 2915
12345